BDD PHARMA LTD

🌳Matureactive

SC212868 · ltd · incorporated 2000-11-15

Investment thesis

Established operating company — standard diligence applies, no dominant angle.

Why interesting: Live, filing, normal profile.

Why risky: No standout signals in either direction.

🔒Estimated value

—

Upgrade to see

Turnover

—

year to Nov 2024

Net worth

—

book net assets

Opportunity

80/100

Exceptional

🔒Generate AI memo →🔒Outreach pack →🔒Corporate story →📑 Reports →Sign in to watch

What this business does

Primary activity: Research and experimental development on biotechnology

Sector: Professional, scientific & technical

Investor take

Pursue

Active trading company with a 82-year-old founder — textbook succession opportunity.

Opportunity 80/100 (exceptional), bankability 67/100. Strong seller-intent signal (73/100, director aged 82). Share purchase looks the cleaner deal structure. Biggest value-creation lever: Consolidate lender relationships. 4 distinct lenders creates friction — refinance into single-lender structure for cleaner diligence. Most likely exit: share sale to pe / searcher (65/100).

🏦

Refinance opportunity

4 live charges · 4 lenders · oldest 22.0y

35/100

too messy

Refinance path is blocked by complexity. Rethink structure or expect bespoke, expensive terms.

· Oldest live charge is 22.0 years old — likely at or near maturity.
· 4 lenders named — inter-creditor friction likely.
· Legal-friction score 30/100 — workable, but lender will want more DD.

Data confidence

Overall: high (82/100)

Strong data coverage across all sections. AI outputs should be trusted with minimal caveats.

Company profile

address, 1 SIC codes, incorporation date

100

Financials

2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed

Lenders & charges

4 charges (4/4 with lender, 4/4 with type)

Directors & officers

16 officers (6 active, 16 linked, 12 with DOB)

Ownership & PSC

1 active PSC(s) of 1 total, 1 with control declared

Director network

11 connected companies via shared directors

Filing history

101 filings on record

Gazette notices

No matching gazette notices (standard for active companies)

Opportunity Score

80/100Exceptional

PassWatchWorth a lookStrongExceptional

Strong composite across quality, acquirability, and risk. High-priority target — progress to serious diligence.

Business quality

Active, clean filings, stable charge profile.

Acquirability

Strong succession / seller-readiness signals.

Risk profile

Few red flags.

Signal strength

100

Good data coverage for analysis.

Key financials

2 years extracted from filed iXBRL accounts

Cash

—

Net Worth

—

Current Assets

—

Current Liabilities

—

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · FRS 102

Metric	2024-11-30	2023-11-30
Average employees	3300	2900

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

3 signals detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days

filings

Last 90 days

filings

Last 180 days

filing

• 1 confirmation-statement

Counts from Companies House filing history.

Corporate timeline (53 events)Click to expand

2025-07-24
📄
accounts-with-accounts-type-total-exemption-full
accounts · AA
2025-05-12
📄
memorandum-articles
incorporation · MA
2025-05-12
📄
resolution
resolution · RESOLUTIONS
2025-05-06
📄
mortgage-create-with-deed-with-charge-number-charge-creation-date
mortgage · MR01
2025-04-28
🔒
Charge registered #4
Lender: Scottish Enterprise
2025-03-07
📄
mortgage-satisfy-charge-full
mortgage · MR04
2025-03-07
🔓
Charge satisfied #3
2024-05-28
📄
accounts-with-accounts-type-total-exemption-full
accounts · AA
2024-04-12
📄
termination-director-company-with-name-termination-date
officers · TM01
2023-12-31
➖
BROWN, Stephen, Dr resigned
director
2023-07-26
📄
mortgage-satisfy-charge-full
mortgage · MR04
2023-07-26
🔓
Charge satisfied #2
2023-06-02
📄
accounts-with-accounts-type-total-exemption-full
accounts · AA
2022-11-29
📄
appoint-person-director-company-with-name-date
officers · AP01
2022-11-29
📍
change-registered-office-address-company-with-date-old-address-new-address
address · AD01
2022-08-26
📄
change-person-director-company-with-change-date
officers · CH01
2022-08-26
📄
appoint-person-director-company-with-name-date
officers · AP01
2022-08-26
📄
accounts-with-accounts-type-total-exemption-full
accounts · AA
2022-08-22
➕
GOW, Laura appointed
director
2022-07-19
📄
appoint-person-director-company-with-name-date
officers · AP01
2022-07-19
📄
appoint-person-director-company-with-name-date
officers · AP01
2022-07-18
📄
appoint-person-director-company-with-name-date
officers · AP01
2022-07-18
📄
change-person-director-company-with-change-date
officers · CH01
2022-05-01
➕
CROCKER, Glenn, Dr appointed
director
2022-05-01
➕
KELLEY, Joanne appointed
director
2022-05-01
➕
MADDEN-SMITH, Claire Elizabeth, Dr appointed
director
2022-05-01
➕
BROWN, Stephen, Dr appointed
director
2021-08-31
📄
accounts-with-accounts-type-total-exemption-full
accounts · AA
2017-07-19
🔒
Charge registered #3
Lender: Clydesdale Bank PLC (Trading as Both Clydesdale and Yorkshire Bank) (Company Number SC001111)
2015-01-13
➖
CONNOLLY, Sarah Mary, Dr resigned
director
2014-08-26
➖
HODGES, Lee Ann, Dr resigned
secretary
2014-08-26
➖
HODGES, Lee Ann, Dr resigned
director
2013-08-25
➖
STILLIE, Ian resigned
director
2013-07-16
➕
THOMSON, Carol Christine, Dr appointed
director
2013-07-16
➕
HODGES, Lee Ann, Dr appointed
secretary
2013-07-16
➖
STEVENS, Howard Norman Ernest, Professor resigned
secretary
2011-10-12
➖
WILSON, Clive George resigned
director
2011-02-19
🔓
Charge satisfied #1
2010-11-01
➕
CONNOLLY, Sarah Mary, Dr appointed
director
2010-10-31
🔒
Charge registered #2
Lender: Clydesdale Bank PLC
2010-08-19
➕
HODGES, Lee Ann, Dr appointed
director
2006-12-04
➖
ELLIOT, Alexander Thomas, Professor resigned
director
2004-04-23
🔒
Charge registered #1
Lender: The Royal Bank of Scotland PLC
2003-09-01
➕
STILLIE, Ian appointed
director
2001-11-07
➕
ELLIOT, Alexander Thomas, Professor appointed
director
2000-11-15
🏢
Company incorporated
As BDD PHARMA LTD
2000-11-15
➕
STEVENS, Howard Norman Ernest, Professor appointed
director
2000-11-15
➕
STEVENS, Howard Norman Ernest, Professor appointed
secretary
2000-11-15
➕
BRIAN REID LTD. appointed
corporate-nominee-secretary
2000-11-15
➖
BRIAN REID LTD. resigned
corporate-nominee-secretary

Showing most recent 50 of 53 events

Owner dependency

65/100

High — earn-out structure required

Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.

FACTORS

-6 active directors: Broader management team in place — suggests transferable governance.
+Long-tenure founder: Senior director has been in place 25 years — deep operational knowledge concentrated in one person.
+Founder age: Director aged approximately 82 — succession pressure is live.

Succession & seller-readiness

90/100

Likely off-market candidate

Strong acquirability signals converging. Worth approaching directly — this is how off-market deals start.

SIGNALS

primaryFounder aged 70+: Senior director is approximately 82 years old. Natural succession window is now.
primary20+ year tenure: Director in role 25 years. Very long tenure is a classic succession signal.
secondaryStable-but-static management: Company is 25 years old and no new directors in the last 3 years — succession not yet being planned internally.
supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.

Red flags

1 med ·

Charge satisfaction-then-recreation pattern

medium

Multiple instances where a charge was satisfied and a new charge created within 6 months. Suggests active refinancing cycle.

Group structure

Bio-Images Drug Delivery Ltd is the ultimate parent — holding 75%+ shares. This company sits inside their group.

🏛️

Bio-Images Drug Delivery Ltd

Corporate parent · holds 75-100% shares

ultimate parent

⬇

BDD PHARMA LTD

This company · SC212868

Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).

Shareholders & ownership

1 active beneficial owner · dominant holder ≥75%

Name	Shares	Voting rights	Nature of control	Notified
Bio-Images Drug Delivery Ltd Corporate entity	75–100%	—	75-100% shares	06/04/2016

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

🔒Co-director network graph

Radial SVG graph showing every company connected via shared directors, colour-coded by status.

Available from the Pro tier upwards.

See pricing →

Similar companies

Active · Professional services · G postcode area

Company	Est. value	Turnover	Net worth	Staff	Age	Opp	Director
BARNETT MANAGEMENT CONSULTING LTD→ SC875758 · est 2026 · no financials extracted	—	—	—	—	—	—	—
BASICS AND BEYOND LIMITED→ SC522457 · est 2015 · no financials extracted	—	—	—	—	10y	—	—
BAXTER ACCOUNTING & TAX SERVICES LIMITED→ SC444781 · est 2013 · no financials extracted	—	—	—	—	13y	—	—
BCA ENGINEERING LTD→ SC848128 · est 2025 · no financials extracted	—	—	—	—	—	—	—
BEATTIE ENERGY COMPLIANCE LTD→ SC821113 · est 2024 · no financials extracted	—	—	—	—	1y	—	—
BELLWETHER GREEN LIMITED→ SC345113 · est 2008 · no financials extracted	—	—	—	—	17y	—	—
BENARTY ENGINEERING LTD→ SC724407 · est 2022 · no financials extracted	—	—	—	—	4y	—	—
BENJAMIN & ISAAC TAX CONSULTANTS LTD→ SC743340 · est 2022 · no financials extracted	—	—	—	—	3y	—	—
BENTALL MICROTURBINE DEVELOPMENTS LIMITED→ SC721126 · est 2022 · no financials extracted	—	—	—	—	4y	—	—
BENTLEY LAW (SCO) LTD→ SC748502 · est 2022 · no financials extracted	—	—	—	—	3y	—	—
BEORGAN LTD→ SC776586 · est 2023 · no financials extracted	—	—	—	—	2y	—	—
BEPS CONULTING LTD→ SC810794 · est 2024 · no financials extracted	—	—	—	—	1y	—	—

Peers ranked by estimated value, then turnover, then opportunity score.See all →

🔒Tailored diligence questions

7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →

🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive

Typeltd

Incorporated2000-11-15

Jurisdictionscotland

Primary SIC72110 — Research and experimental development on biotechnology

Registered office

Bio Imaging Unit, Basement Medical Block Within Glasgow Royal Infirmary

84 Castle Street

Glasgow

G4 0SF

Scotland

Filing status

Accounts

Next due: 2026-08-31

Last made up to: 2024-11-30

Confirmation statement

Next due: 2026-11-29

Last: 2025-11-15